Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Sleeping Through Menopause
NCT06306404Phase 4Not yet recruiting
- Sponsor
- Vrije Universiteit Amsterdam
- Start
- Oct 2025
- Primary completion
- Oct 2029
- Modality
- Hormone, Biologic
01
Overview
Phase 4, randomised, open-label trial of estradiol in Insomnia and menopause (4 arms), sponsored by Vrije Universiteit Amsterdam. Primary endpoint: Change in Insomnia Severity Index at 4 months. Planned start Oct 2025; status: not yet recruiting.
02
Drugs
estradiol
03
Conditions
Insomniamenopause
Beyond the preview
Go deeper on NCT06306404.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06306404.